John Begley

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Laurene H. Wang, John Begley, R. L. St. Claire et al. · AIDS Research and Human Retroviruses · 2004 · 125 citations

Medicine, Pharmacokinetics, Pharmacology +11

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Laurene H. Wang, John Begley, Robert L. St. Claire et al. · AIDS Research and Human Retroviruses · 2004 · 109 citations

Medicine, Pharmacokinetics, Pharmacology +11

Steady‐State Pharmacokinetics of Emtricitabine and Tenofovir Disoproxil Fumarate Administered Alone and in Combination in Healthy Volunteers

Martin Blum, Gregory E. Chittick, John Begley et al. · The Journal of Clinical Pharmacology · 2007 · 78 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Rapid Enantiomeric Quantification of an Antiviral Nucleoside Agent (<scp>d</scp>,<scp>l</scp>-FMAU, 2‘-Fluoro-5-methyl-β,<scp>d</scp>,<scp>l</scp>-arabinofurano- syluracil) by Mass Spectrometry

W. Andy Tao, Lianming Wu, R. Graham Cooks et al. · Journal of Medicinal Chemistry · 2001 · 48 citations

Pharmacy, Medicinal Chemistry, Pharmaceutical Analysis +14

Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady State

Gregory E. Chittick, Jian Zong, Martin Blum et al. · Antimicrobial Agents and Chemotherapy · 2006 · 46 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13